PUTRAJAYA, 6th April 2020 – The “Solidarity Trial”, launched by the World Health Organization (WHO), will see Malaysia’s involvement in an international effort to test several drugs in treating COVID-19.
The WHO globally coordinated trial is an unprecedented effort to collect reliable data and compare the safety and effectiveness of four treatment protocols using different combinations of Remdesivir, Lopinavir/Ritonavir, Interferon beta, Chloroquine and Hydroxychloroquine.
The Director General of Health, Ministry of Health (MOH) Malaysia Datuk Dr Noor Hisham Abdullah said, MOH has fast-tracked the process to implement the drug trials to treat patients with COVID-19, which will begin soon.